This is an overview of vaccinations commonly given to dogs.   You can return to the main article about the risks and benefits of vaccinating dogs here.

 

Canine distemper virus (CDV)

Canine distemper is a highly contagious disease that affects the respiratory, gastrointestinal, and central nervous systems. Puppies from 3 to 6 months are especially susceptible and are more likely to die from the disease than affected adults.

Vaccine Type: MLV or rCDV
Initial Vaccination (<16 wk of age): Every 3-4 weeks between ages of 6 and 16 weeks. First booster: after 1 year
Initial Vaccination (>16 wk of age): One dose is considered protective. First booster: after 3 years
Revaccination (Booster): Every 3 years
AAHA Core/Non-Core: Core

 

Measles (MV)

Measles vaccine is only intended to provide temporary immunization of young puppies against CDV.

Vaccine Type:  MLV
Initial Vaccination (<16 wk of age): A single dose for administration to a healthy puppy between 6-12 weeks
Initial Vaccination (>16 wk of age): Not recommended
Revaccination (Booster): Not recommended
AAHA Core/Non-Core: Noncore

 

Canine Parvovirus (CPV-2)

Parvovirus is a highly contagious disease that spreads to the bloodstream and attacks rapidly dividing cells throughout the body.

Vaccine Type: MLV
Initial Vaccination (<16 wk of age): Every 3-4 weeks between ages of 6 and 16 weeks. First booster: after 1 year
Initial Vaccination (>16 wk of age): One dose is considered protective. First booster: after 3 years
Revaccination (Booster): Every 3 years
AAHA Core/Non-Core: Core

 

Canine Adenovirus Type 2 (CAV-2)

CAV-2 induces protection against CAV-1 (canine hepatitis virus) as well as CAV-2 (one of the agents known to be associated with canine infectious respiratory disease).

Vaccine Type: MLV – for parenteral administration
Initial Vaccination (<16 wk of age): Every 3-4 weeks between ages of 6 and 16 weeks. First booster: after 1 year
Initial Vaccination (>16 wk of age): One dose is considered protective. First booster: after 3 years
Revaccination (Booster): Every 3 years
AAHA Core/Non-Core: Core

 

Canine Adenovirus Type 2 (CAV-2 IN)

CAV-2 induces protection against CAV-1 (canine hepatitis virus) as well as CAV-2 (one of the agents known to be associated with canine infectious respiratory disease).  The CAV-2 IN vaccine is only available in combination with a core vaccines (IN Bb and CPiV) and administration should follow the same recommendations as for the core vaccines. CAV-2 IN may not provide immunity against CAV-1 virus.

Vaccine Type: MLV – for intra-nasal administration
Initial Vaccination (<16 wk of age): Single dose in conjunction with 1 of the core vaccine doses
Initial Vaccination (>16 wk of age): Single dose is recommended
Revaccination (Booster): Annually or more often in high-risk areas
AAHA Core/Non-Core: Noncore

 

Rabies (1 year)

Rabies causes encephalitis in both dogs and humans. Once symptoms develop, this disease is almost always fatal. In the United States and most other foreign countries, rabies shots are required by law.

Vaccine Type: killed virus
Initial Vaccination (<16 wk of age): Single dose of “1-year” vaccine after 12 wk or as required by law. First booster: after 1 year
Initial Vaccination (>16 wk of age): Single dose of “1-year” vaccine is considered protective
Revaccination (Booster): Annually
AAHA Core/Non-Core: Core


Rabies (3 year; alternative to 1-year variant)

Rabies causes encephalitis in both dogs and humans. Once symptoms develop, this disease is almost always fatal. In the United States and most other foreign countries, rabies shots are required by law.

Vaccine Type: killed virus
Initial Vaccination (<16 wk of age): Single dose of “3-year” vaccine after 12 wk or as required by law. First booster: after 1 year
Initial Vaccination (>16 wk of age): Single dose of “3-year” vaccine is considered protective
Revaccination (Booster): Every 3 years
AAHA Core/Non-Core: Core

 

Canine Parainfluenza Virus (CPiV) – MLV

Canine Parainfluenza is a respiratory disease. The CPiV vaccine is only available in combination with a core vaccines (CDV, CPV-2 and CAV-2) and administration should follow the same recommendations os for the core vaccines.

Vaccine Type: MLV – for parenteral administration
Initial Vaccination (<16 wk of age): Follow core vaccine administration recommendation
Initial Vaccination (>16 wk of age): Follow core vaccine administration recommendation
Revaccination (Booster): Annually
AAHA Core/Non-Core: Noncore

 

Canine Parainfluenza Virus (CPiV) – IN

Canine Parainfluenza is a respiratory disease. The CPiV vaccine is only available in combination with a core vaccines (IN Bb or Bb + CAV-2) and administration should follow the same recommendations os for the core vaccines.

Vaccine Type: MLV – for intra-nasal administration
Initial Vaccination (<16 wk of age): Single dose in conjunction with 1 of the core vaccine doses
Initial Vaccination (>16 wk of age): Single dose is recommended
Revaccination (Booster): Annually or more often in high-risk areas
AAHA Core/Non-Core: Noncore

 

Bordatella (Bb, aka kennel cough)

Kennel cough is a is a disease frequently contracted in shelters, kennels and grooming facilities.

Vaccine Type: Inactivated cellular antigen extract for parenteral administration or live avirulent bacteria for Intra Nasal administration
Initial Vaccination (<16 wk of age): Single dose at 8 wk of age and second at 12 wk.
Initial Vaccination (>16 wk of age): Two does, 2-4 wk apart are required
Revaccination (Booster): Annually (intra nasal vaccine more frequently is high-risk areas)
AAHA Core/Non-Core: Core
For more information about Kennel Cough, download this document.

 

Canine Influenza Vaccine

Canine influenza is a respiratory disease.

Vaccine Type: killed virus
Initial Vaccination (<16 wk of age): Single dose after 6 wk of age and second dose 4 wk later
Initial Vaccination (>16 wk of age): Two doses 2-4 wk apart are required
Revaccination (Booster): Annually or more often in high-risk areas
AAHA Core/Non-Core: Noncore

 

Borrelia Burgdorferi (Lyme disease)

Causes swollen glants and joints, similar to the human disease.

Vaccine Type: killed whole cell bacteria
Initial Vaccination (<16 wk of age): Single dose after 12 wk of age and second dose 2-4 wk later
Initial Vaccination (>16 wk of age): Two doses 2-4 wk apart are required
Revaccination (Booster): Annually, best if administered before start of tick season
AAHA Core/Non-Core: Noncore

 

Leptospira interrogans

Leptospira cause leptospirosis, an often fatal liver or kidney disease. Within this species there are many different strains (serovars). Unfortunately, vaccination against one strain does not protect against the other strains.

Vaccine Type: 4-way killed whole cell or subunit bacterin
Initial Vaccination (<16 wk of age): Single dose after 12 wk of age and second dose 2-4 wk later
Initial Vaccination (>16 wk of age): Two doses 2-4 wk apart are required
Revaccination (Booster): Annually, boosters should be limited to dogs with a risk of exposure
AAHA Core/Non-Core: Noncore

 

Crotalus atrox

Western Diamond rattlesnake vaccine

Vaccine Type: toxoid
Initial Vaccination (<4 mo of age): Not recommended
Initial Vaccination (>4 mo of age): Dose may depend on size of dog, current recommendation is 2 doses, 1 month apart
Revaccination (Booster): Annually, boosters should be limited to dogs with a risk of exposure
AAHA Core/Non-Core: Noncore

 

Canine coronavirus (CCoV)

Disease infecting the dog’s intestinal tract

Vaccine Type: Killed virus and MLV
Initial Vaccination (<4 mo of age): Not recommended
Initial Vaccination (>4 mo of age): Not recommended
Revaccination (Booster): annually, Not recommended
AAHA Core/Non-Core: Not recommended

 

For more information, download the 2011 AAHA Canine Vaccination Guidelines.

You can return to the main article about the risks and benefits of vaccinating dogs here.

 

Leave a reply